Another Dismal Quarter for BSX – Analyst Blog

By | October 18, 2012

Boston Scientific ( BSX ) reported a net loss of $725 million or 52 cents per share in the third quarter of 2012, a disappointment from net income of $142 million or earnings per share

Visit site:
Another Dismal Quarter for BSX – Analyst Blog